CFMS logo

Conformis, Inc. Stock Price

NasdaqCM:CFMS Community·US$17.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CFMS Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.

CFMS Community Narratives

There are no narratives available yet.

Snowflake Analysis

Fair value with mediocre balance sheet.

5 Risks
2 Rewards

Conformis, Inc. Key Details

US$57.1m

Revenue

US$38.1m

Cost of Revenue

US$18.9m

Gross Profit

US$60.4m

Other Expenses

-US$41.5m

Earnings

Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
-5.27
33.21%
-72.73%
64.4%
View Full Analysis

About CFMS

Founded
2004
Employees
295
CEO
Mark Augusti
WebsiteView website
www.conformis.com

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

Recent CFMS News & Updates

Recent updates

No updates